Mutations in the regulatory domain of phenylalanine hydroxylase and response to tetrahydrobiopterin.
暂无分享,去创建一个
R. Stevens | R. Matalon | R. Koch | K. Michals‐Matalon | S. Surendran | S. Tyring | F. Guttler | J. Grady | Lin Wang | G. Bhatia | Susan Tanskley | Kimberlee Michals‐Matalon
[1] K. Michals‐Matalon,et al. Sapropterin dihydrochloride, 6-R-L-erythro-5,6,7,8-tetrahydrobiopterin, in the treatment of phenylketonuria , 2008, Expert opinion on investigational drugs.
[2] Kinetic and stability analysis of PKU mutations identified in BH4-responsive patients. , 2005, Molecular genetics and metabolism.
[3] R. Stevens,et al. Structure-based chemical modification strategy for enzyme replacement treatment of phenylketonuria. , 2005, Molecular genetics and metabolism.
[4] R. Stevens,et al. Correction of kinetic and stability defects by tetrahydrobiopterin in phenylketonuria patients with certain phenylalanine hydroxylase mutations. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[5] R. Stevens,et al. Mechanisms underlying responsiveness to tetrahydrobiopterin in mild phenylketonuria mutations , 2004, Human mutation.
[6] N. Blau,et al. The metabolic and molecular bases of tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency. , 2004, Molecular genetics and metabolism.
[7] Aurora Martínez,et al. Structural and stability effects of phosphorylation: Localized structural changes in phenylalanine hydroxylase , 2004, Protein science : a publication of the Protein Society.
[8] R. Stevens,et al. Biopterin responsive phenylalanine hydroxylase deficiency , 2004, Genetics in Medicine.
[9] J. Zschocke. Phenylketonuria mutations in Europe , 2003, Human mutation.
[10] Knut Teigen,et al. Phosphorylation and Mutations of Ser16 in Human Phenylalanine Hydroxylase , 2002, The Journal of Biological Chemistry.
[11] J. Denecke,et al. Tetrahydrobiopterin responsiveness in a large series of phenylke tonuria patients , 2002, Journal of Inherited Metabolic Disease.
[12] P. Guldberg,et al. Missense mutations in the N-terminal domain of human phenylalanine hydroxylase interfere with binding of regulatory phenylalanine. , 2001, American journal of human genetics.
[13] E. Mayatepek,et al. Tetrahydrobiopterin responsiveness in phenylketonuria differs between patients with the same genotype. , 2001, Molecular genetics and metabolism.
[14] M J Sternberg,et al. Enhancement of protein modeling by human intervention in applying the automatic programs 3D‐JIGSAW and 3D‐PSSM , 2001, Proteins.
[15] C R Scriver,et al. PAHdb: A locus‐specific knowledgebase , 2000, Human mutation.
[16] S. Kure,et al. Tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency. , 1999, The Journal of pediatrics.
[17] R. Stevens,et al. Structural basis of autoregulation of phenylalanine hydroxylase , 1999, Nature Structural Biology.
[18] R. Stevens,et al. Crystal structure of the catalytic domain of human phenylalanine hydroxylase reveals the structural basis for phenylketonuria , 1997, Nature Structural Biology.
[19] R. Matalon,et al. Phenylketonuria: current dietary treatment practices in the United States and Canada. , 1997, Journal of the American College of Nutrition.
[20] P. Guldberg,et al. Molecular analysis of phenylketonuria in Denmark: 99% of the mutations detected by denaturing gradient gel electrophoresis. , 1993, Genomics.
[21] R. Koch,et al. Blood phenylalanine levels and intelligence of 10-year-old children with PKU in the National Collaborative Study. , 1988, Journal of the American Dietetic Association.
[22] H. Bickel,et al. Influence of phenylalanine intake on phenylketonuria. , 1953, Lancet.